JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB133582

Anti-CD73 antibody [EPR6114]

3

(2 Reviews)

|

(34 Publications)

Anti-CD73 antibody [EPR6114] (ab133582) is a rabbit monoclonal antibody detecting CD73 in Western Blot, IHC-P. Suitable for Human samples.

Enhanced IHC validation data - Download the data
- IHC KO validated for confirmed specificity
- detailed IHC expression profiling in normal and clinically relevant cancer FFPE TMAs- lung, breast and rectal
- protocol for BOND RX™
Over 20 publications
Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

CD73, NT5, NTE, NT5E, 5'-nucleotidase, 5'-NT, 5'-deoxynucleotidase, Ecto-5'-nucleotidase, IMP-specific 5'-nucleotidase, Thymidylate 5'-phosphatase

8 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human spleen tissue sections labeling CD73 with Purified ab133582 at 1 : 2000 dilution (1.12 μg/ml).

Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer pH 9.0).

ImmunoHistoProbe one step HRP Polymer (ready to use) was used.

Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lung carcinoma tissue sections labeling CD73 with Purified ab133582 at 1 : 2000 dilution (1.12 μg/ml).

Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0).

ImmunoHistoProbe one step HRP Polymer (ready to use)was used.

Negative control : PBS instead of the primary antibody.

Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labelling CD73 with ab133582 at 1/100 dilution.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD73 antibody [EPR6114] (AB133582)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human liver tissue sections labeling CD73 with Purified ab133582 at 1 : 2000 dilution (1.12 μg/ml).

Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer pH 9.0).

ImmunoHistoProbe one step HRP Polymer (ready to use) was used.

Negative control : PBS instead of the primary antibody.

Hematoxylin was used as a counterstain.

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)
  • WB

Lab

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)

False colour image of Western blot : Anti-CD73 antibody [EPR6114] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab133582 was shown to bind specifically to CD73. A band was observed at 70 kDa in wild-type A-375 cell lysates with no signal observed at this size in NT5E knockout cell line ab281591 (knockout cell lysate ab282943). To generate this image, wild-type and NT5E knockout A-375 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-CD73 antibody [EPR6114] (ab133582) at 1/1000 dilution

Lane 1:

Wild-type A-375 cell lysate at 20 µg

Lane 2:

NT5E knockout A-375 cell lysate at 20 µg

Lane 3:

A431 cell lysate at 20 µg

Lane 4:

HepG2 cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Lanes 1 - 4:

Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution

Observed band size: 70 kDa

false

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)
  • WB

Unknown

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)

All lanes:

Western blot - Anti-CD73 antibody [EPR6114] (ab133582) at 1/1000 dilution

Lane 1:

Human fetal liver tissue lysate at 10 µg

Lane 2:

A375 cell lysate at 10 µg

Lane 3:

HepG2 cell lysate at 10 µg

Secondary

All lanes:

HRP labelled Goat anti-Rabbit IgG at 1/2000 dilution

Predicted band size: 63 kDa

false

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)
  • WB

Lab

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)

Lanes 1 - 3 : Merged signal (red and green). Green - ab133582 observed at 63 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab133582 was shown to recognize NT5E in wild-type A-431 cells as signal was lost at the expected MW in NT5E knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and NT5E knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% Milk. ab133582 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CD73 antibody [EPR6114] (ab133582) at 1/1000 dilution

Lane 1:

Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

NT5E knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

Western blot - Human NT5E knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-nt5e-knockout-a-431-cell-line-ab261895'>ab261895</a>)

Lane 3:

A-375 (Human malignant melanoma cell line) whole cell lysate at 20 µg

Predicted band size: 105 kDa,143 kDa,24 kDa,35 kDa,41 kDa,44 kDa,45 kDa,53 kDa,58 kDa,61 kDa,62 kDa,63 kDa,70 kDa,88 kDa

Observed band size: 104 kDa,18 kDa,55 kDa,58 kDa

false

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)
  • WB

Unknown

Western blot - Anti-CD73 antibody [EPR6114] (AB133582)

All lanes:

Western blot - Anti-CD73 antibody [EPR6114] (ab133582) at 1/1000 dilution

All lanes:

A375 ( Human malignant melanoma epithelial cell) whole cell lysates at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 63 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR6114

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p>For unpurified use ad 1/100 - 1/250.</p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-CD73 antibody [EPR6114] (ab133582) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of CD73?
Anti-CD73 [EPR6114] (ab133582) specifically detects a band for CD73 (UniProt: P21589) at a molecular weight of 63kDa.

Trusted by the scientific community
Anti-CD73 [EPR6114] (ab133582) was first used in a scientific publication in 2012 and has been cited over 20 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-CD73 antibody [EPR6114] (ab133582) has been confirmed by Western blot testing in NT5E Knockout A431 cells.

Other related products
We have a range of other formats of antibody clone [EPR6114] also available for your convenience: ab133582, Carrier free - ab227113, Carrier free - ab271895, Alexa Fluor® 488 - ab311037, Alexa Fluor® 647 - ab311163, Alexa Fluor® 594 - ab311813, Alexa Fluor® 568 - ab313096, Alexa Fluor® 555 - ab313289, Alexa Fluor® 750 - ab321057

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD73 also known as ecto-5'-nucleotidase is an enzyme that functions at the cellular level. The CD73 protein hydrolyzes extracellular nucleotides into nucleosides by removing phosphate groups. It is a 70 kDa glycosylphosphatidylinositol-anchored molecule found on the surface of various cell types including endothelial cells lymphocytes and epithelial cells. Its presence is noted in a wide range of tissues across the human body highlighting its versatile role in cellular communication and metabolism.
Biological function summary

CD73 participates in the regulation of purinergic signaling through adenosine production. It acts in cooperation with other cell surface enzymes such as CD39 forming a functional complex that handles ATP breakdown to adenosine. This enzymatic activity modulates immune responses tissue protection and inflammation control. In addition to immune-related functions CD73 supports the maintenance of vascular integrity and proper cellular adhesion which is important in different physiological and pathological contexts.

Pathways

CD73 plays an important part in the adenosinergic pathway governing the conversion of AMP into adenosine. This activity impacts the signaling and function of the adenosine receptors on immune and non-immune cells. Another important pathway is the angiogenesis process where CD73 contributes by affecting endothelial cell migration and blood vessel development. Relationships with key proteins such as adenosine A2 receptors help facilitate these critical pathway activities.

CD73's involvement with immunosuppression and tumor progression becomes significant. Elevated levels of CD73 are frequently observed in some cancers where it aids in creating a favorable tumor microenvironment through increased adenosine production. This situation assists tumor cells in evading immune detection. Additionally CD73 is linked to autoimmune diseases like multiple sclerosis where it contributes to modulated lymphocyte activity. Connections with proteins such as TGF-beta further illustrate its role in disease-related pathways creating potential targets for therapeutic interventions through the use of anti-CD73 antibodies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, with AMP being the preferred substrate (PubMed : 21933152, PubMed : 22997138, PubMed : 23142347, PubMed : 24887587, PubMed : 34403084). Shows a preference for ribonucleotide monophosphates over their equivalent deoxyribose forms (PubMed : 34403084). Other substrates include IMP, UMP, GMP, CMP, dAMP, dCMP, dTMP, NAD and NMN (PubMed : 21933152, PubMed : 22997138, PubMed : 23142347, PubMed : 24887587, PubMed : 34403084).
See full target information NT5E

Publications (34)

Recent publications for all applications. Explore the full list and refine your search

Future science OA 11:2471723 PubMed40035430

2025

Biodistribution and persistence of human umbilical cord-derived mesenchymal stem cells in NCG mice: a comparative study.

Applications

Unspecified application

Species

Unspecified reactive species

Guangyang Liu,Herui Wang,Xin Li,Yi Mi,Chenliang Zhang,Yaoyao Chen,Li Miao,Haomiao Long,Jun He,Qinggang Ge,Yongjun Liu

International journal of nanomedicine 20:91-107 PubMed39802376

2025

Apoptotic Vesicles Attenuate Acute Lung Injury CD73-Mediated Inhibition of Platelet Activation and NETosis.

Applications

Unspecified application

Species

Unspecified reactive species

Lingping Tan,Chi Zhang,Xiaoxing Kou,Lu Zhao,Di Wu,Jinyu Li,Chuanying Yu,Tansi Xu,Li Gao,Xueli Mao,Chuanjiang Zhao

American journal of translational research 16:4020-4031 PubMed39262711

2024

Improvement of endometrial thickness and fertilization outcomes in patients with Asherman's refractory endometrium using autologous mesenchymal stem cells from the stromal vascular fraction.

Applications

Unspecified application

Species

Unspecified reactive species

Dinorah Hernández-Melchor,Ginna Ortiz,Iván Madrazo,Juan José Suarez,Norma Barrera,Leonardo M Porchia,Fernando Chávez,Francisco Velázquez-Aranda,Aarón González-Espinosa,América Padilla,Esther López-Bayghen

Journal of extracellular vesicles 13:e12480 PubMed38978304

2024

The immunomodulatory ballet of tumour-derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD-L1 pathway in cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Dominique S Rubenich,Jordana L Domagalski,Gabriela F S Gentil,Jonas Eichberger,Mathias Fiedler,Florian Weber,Marianne Federlin,Hendrik Poeck,Torsten E Reichert,Tobias Ettl,Richard J Bauer,Elizandra Braganhol,Daniela Schulz

Scientific reports 14:11609 PubMed38773214

2024

Uracil as a biomarker for spatial pyrimidine metabolism in the development of gingivobuccal oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Soni Shaikh,Sangramjit Basu,Swarnendu Bag,Ankita Chatterjee,Sourav Datta,Devmalya Banerjee,Kapila Manikantan,Indu Arun,Pattatheyil Arun,Nidhan K Biswas,Arindam Maitra,Deepak Kumar Mishra,Partha P Majumder,Harsh Dhar,Geetashree Mukherjee

Cancer medicine 12:19904-19920 PubMed37792675

2023

Dynamic ultrasound molecular-targeted imaging of senescence in evaluation of lapatinib resistance in HER2-positive breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoyu Chen,Ying Li,Zhiwei Zhou,Yanqiu Zhang,Luchen Chang,Xiujun Gao,Qing Li,Hao Luo,Kenneth D Westover,Jialin Zhu,Xi Wei

Biomedicines 11: PubMed37509688

2023

A2AR Expression and Immunosuppressive Environment Independent of and Mutations in Pseudomyxoma Peritonei.

Applications

Unspecified application

Species

Unspecified reactive species

Shigeki Kusamura,Adele Busico,Elena Conca,Iolanda Capone,Luca Agnelli,Daniele Lorenzini,Silvia Brich,Marta Angelini,Chiara Costanza Volpi,Desirè Viola Trupia,Vincenzo Lagano,Tommaso Torelli,Annunziata Gloghini,Dario Baratti,Marcello Guaglio,Massimo Milione,Marcello Deraco,Federica Perrone

Experimental and therapeutic medicine 25:272 PubMed37206543

2023

CD73 blockade alleviates intestinal inflammatory responses by regulating macrophage differentiation in ulcerative colitis.

Applications

Unspecified application

Species

Unspecified reactive species

Ru Wang,Yan Wang,Chao Wu,Guiyuan Jin,Fengqin Zhu,Yonghong Yang,Yibo Wang,Guangxi Zhou

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e22684 PubMed36468677

2022

CD73-generated extracellular adenosine promotes resolution of neutrophil-mediated tissue injury and restrains metaplasia in pancreatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Baylee J O'Brien,Erika Y Faraoni,Lincoln N Strickland,Zhibo Ma,Victoria Mota,Samantha Mota,Xuebo Chen,Tingting Mills,Holger K Eltzschig,Kathleen E DelGiorno,Jennifer M Bailey-Lundberg

Translational cancer research 11:3634-3644 PubMed36388013

2022

High expression of CD73 contributes to poor prognosis of clear-cell renal cell carcinoma by promoting cell proliferation and migration.

Applications

Unspecified application

Species

Unspecified reactive species

Yihong Zhou,Dong Jiang,Xi Chu,Minbo Yan,Hao Qi,Xiang Wu,Yuxin Tang,Yingbo Dai
View all publications
enhancedValidationDataWebsite
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com